rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Bluejay Diagnostics, Inc.

BJDX · Nasdaq

Health CareMedical DevicesNot moving yet

BJDX stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 56.9% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$443K
Insider sales, 12 months
$98K
Officials’ trades on record
0
Institutions holding
8 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$85K$0$237KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months6
Sale orders, 12 months1
Buyers · sellers6 · 1
WhoDidSharesTraded
Hrt Financial Lp10% ownersold34,938at $1.4010 Jul 2026filed 13 Jul 2026
Hrt Financial Lp10% ownerbought64,047at $1.519 Jul 2026filed 13 Jul 2026
Svetlana DeyDirectorbought12,500at $2.0014 Mar 2026filed 18 May 2026
Fred S. ZeidmanDirectorbought12,500at $2.0014 Mar 2026filed 18 May 2026
Donald R. ChaseDirectorbought12,500at $2.0014 Mar 2026filed 18 May 2026
Indranil DeyPresident and CEObought12,500at $2.0014 Mar 2026filed 18 May 2026
Douglas Clark WurthDirectorbought12,500at $2.0014 Mar 2026filed 18 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders8+2 on the quarter
New · exited5 · 3
Reported value$259K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
ARMISTICE CAPITAL, LLCnew · filed 14 Aug 2026131,000$157K+131,000
HEIGHTS CAPITAL MANAGEMENT, INCnew · filed 14 Aug 202635,400$42K+35,400
BOOTHBAY FUND MANAGEMENT, LLCnew · filed 14 Aug 202627,130$33K+27,130
BANK OF AMERICA CORPnew · filed 14 Aug 202610,337$12K+10,337
VANGUARD FIDUCIARY TRUST COnew · filed 13 Aug 202610,225$12K+10,225
Tower Research Capital LLC (TRC)added · filed 11 Aug 20261,907$2,288+178+10.3%
L1 Global Manager Pty Ltdunchanged · filed 13 Aug 2026120$14400.0%
Caitong International Asset Management Co., Ltdreduced · filed 5 Aug 20261$1-2−66.7%
31 Mar 2023 – 30 Jun 2026
1611Mar 23Jun 24Mar 25Sep 25Jun 26

Everyone who traded it

Donald R. Chase Company insiderDirector · last 17 Aug 20261 · 0
Douglas Clark Wurth Company insiderDirector · last 17 Aug 20263 · 0
Fred S. Zeidman Company insiderDirector · last 17 Aug 20261 · 0
Indranil Dey Company insiderPresident and CEO · last 17 Aug 20264 · 0
Svetlana Dey Company insiderDirector · last 17 Aug 20264 · 0
HRT FINANCIAL LP Company insider10% owner · last 10 Jul 20261 · 1
Gary G. Gemignani Company insiderDirector · last 1 Feb 20230 · 0
Kenneth R. Fisher Company insiderChief Financial Officer · last 1 Feb 20232 · 0
Gordon Winston Kinder Company insiderChief Financial Officer · last 17 Mar 20224 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-116%
Share count trendFY 2025 · to 2 Mar 202660.8%
Cash and equivalentsFY 2025 · to 31 Dec 2025$5.2M
Free cash flowFY 2025 · to 31 Dec 2025−$6.2M

Analyst forecasts

No analyst forecasts yet.